Review Article
The Glomerular Filtration Barrier: Components and Crosstalk
Table 1
Classification of glomerular injury by pathomechanism.
(a) Inherited |
| Proteins involved in podocyte cytoskeletal integrity [4] | | Podocin (AR), nephrin (AR), CD2-associated protein (AD), transient receptor potential cation-6 (AD), α-actinin-4 (AD), phospholipase-Cα1 (AR), tetraspanin CD-151 (AR), and Wilm’s tumor-1 (AD) | | Basement membrane proteins [9, 11] | | Alport’s syndrome-α-4 collagen-5 (XL~85%); Alport’s syndrome-α-4 collagen-3/4 (AR or AD~15%), thin Basement membrane disease (AD), and laminin-β2 (AR) | | Proteins involved in endothelial/microvascular integrity [12, 15] | | Complement regulatory proteins—complement factors H and I (AD), membrane cofactor protein (AD), and complement C3 (Gain-of-function) | | Lysosomal storage diseases—metabolic injury [9] | | Fabry’s disease (XL) | |
|
|
(b) Acquired |
| Immune | Nonimmune | Idiopathic |
| Immune complex mediated [13, 15] | Hemodynamic injury [10] | Unclear mechanisms | In situ formation or circulating complexes (postinfectious glomerulonephritis—streptococcal, | Hypertension | Minimal-change disease [22] | hepatits B/hepatitis-C-associated GN, systemic lupus erythematosus, | Adaptive hyperfiltration (nephron loss) | Membranous nephropathy [14] | and IgA nephropathy) idiopathic MP GN (types I and III) | Other | Primary FSGS [10] | Antibody-mediated [13] | Metabolic-hyperglycemia in diabetes | | Anti-GBM antibody disease | Deposition disease- Amyloidosis | | T-cell-mediated injury [13] | Toxic—Pamidronate, NSAIDs, D-pencillamine, and gold | | Antineutrophil cytoplasm antibody vasculitis, most glomerulonephritides | Infectious—HIV [10] | | Complement-mediated injury [12, 15] | | | MPGN type II, atypical HUS | | |
|
|
Inheritance pattern—autosomal recessive (AR), dominant (AD), and X-linked (XL).
|